Jim McManus is the Director of Public Health for Hertfordshire. The document discusses strategies to address vaccine hesitancy for the COVID-19 vaccine. It defines vaccine hesitancy and outlines approaches for building confidence in the vaccine, including providing accurate information, acknowledging concerns, and promoting peer influence and role models. Barriers to vaccine uptake are addressed at both the organizational and individual level.
• Vaccination and how it works?
• Herd Immunity
• COVID-19 vaccines in India
• Who can take the vaccine?
• What to expect during and after vaccination?
• Vaccine Hesitancy
• Determinants of Vaccine Hesitancy
Webinar Series on COVID-19 vaccine: Jointly organized by Malaysian Society of Infection Control and Infectious Diseases (MyICID) & Institute for Clinical Research (ICR), NIH
Speaker: Dr. Low Lee Lee, Infectious Disease Physician at the Hospital Sultanah Bahiyah, Ministry of Health Malaysia.
RTS,S/AS01 (RTS,S) is a malaria vaccine that has been developed through a partnership between GlaxoSmithKline Biologicals (GSK) and the PATH Malaria Vaccine Initiative (MVI), with support from the Bill & Melinda Gates Foundation and from a network of African research centers that performed the studies.
• Vaccination and how it works?
• Herd Immunity
• COVID-19 vaccines in India
• Who can take the vaccine?
• What to expect during and after vaccination?
• Vaccine Hesitancy
• Determinants of Vaccine Hesitancy
Webinar Series on COVID-19 vaccine: Jointly organized by Malaysian Society of Infection Control and Infectious Diseases (MyICID) & Institute for Clinical Research (ICR), NIH
Speaker: Dr. Low Lee Lee, Infectious Disease Physician at the Hospital Sultanah Bahiyah, Ministry of Health Malaysia.
RTS,S/AS01 (RTS,S) is a malaria vaccine that has been developed through a partnership between GlaxoSmithKline Biologicals (GSK) and the PATH Malaria Vaccine Initiative (MVI), with support from the Bill & Melinda Gates Foundation and from a network of African research centers that performed the studies.
Influenza vaccines or flu shots protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Their effectiveness varies from year to year, most provide modest to high protection against influenza.
The Power of Vaccines: ‘getting to zero’ for HIV and TB was an event hosted by the TB/HIV and Prevention Working Groups of the UK Consortium on AIDS and International Development. The meeting was sponsored by Pamela Nash MP and held on Friday, 18th May 2012, in Portcullis House, Westminster. Read more at http://storify.com/PamojaUK/the-power-of-vaccines
http://www.pamoja.uk.com
This PPT comprises of brief history of vaccines and its details, concentrated on adverse reactions due to various vaccines, and briefly bout the cold chain.
This important presentation encompasses all the vaccines of COVID at current point of time; it's mechanism of action, its efficacy data's and advantages and disadvantages
A brief overview of the process of vaccine production, clinical trials, and licensing, along with a summary of the different vaccines platforms and vaccine candidates.
Influenza vaccines or flu shots protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Their effectiveness varies from year to year, most provide modest to high protection against influenza.
The Power of Vaccines: ‘getting to zero’ for HIV and TB was an event hosted by the TB/HIV and Prevention Working Groups of the UK Consortium on AIDS and International Development. The meeting was sponsored by Pamela Nash MP and held on Friday, 18th May 2012, in Portcullis House, Westminster. Read more at http://storify.com/PamojaUK/the-power-of-vaccines
http://www.pamoja.uk.com
This PPT comprises of brief history of vaccines and its details, concentrated on adverse reactions due to various vaccines, and briefly bout the cold chain.
This important presentation encompasses all the vaccines of COVID at current point of time; it's mechanism of action, its efficacy data's and advantages and disadvantages
A brief overview of the process of vaccine production, clinical trials, and licensing, along with a summary of the different vaccines platforms and vaccine candidates.
The epidemic of misinformation about vaccinesCILIP
Dr Pauline Paterson's (Research Fellow and co-director of The Vaccine Confidence Project, London School of Hygiene & Tropical Medicine) presentation at the CILIP 2017 Conference in Manchester #CILIPConf17
Whilst most people vaccinate, some groups or individuals delay or refuse vaccines due to concerns about safety, whether real or perceived, and concerns about information (including mis-information or mis-trust in information). Public concerns about vaccines have occurred around the world, spreading quickly and sometimes leading to vaccine refusals and disease outbreaks.
The presentation will explore case studies on non-vaccination of measles containing vaccine (MCV) and concerns around HPV vaccine globally. This talk will attempt to address the question of how misinformation can undermine public health, exploring selective exposure, selective perception and the issue of multiple realities.
It is a universal truth that children must be given the appropriate vaccine at the appropriate age. Providing various vaccines at a given age saves kids from diseases that are life-threatening. Until and unless the kids are informed about the health hazards, they won’t realize the vaccine awareness they should be having.
In this webinar, Dr. Anne Schuchat, principal deputy director of the CDC, and Charysse Nunez, insights lead for the Ad Council’s COVID Campaign, provided updates on the COVID-19 pandemic, vaccinations, and communications efforts. This webinar was put on by the Public Health Communications Collaborative.
How to combat misinformation on vaccines and other public health issuesWilliam D Leach
Research on metacognition yields eight communication strategies for inoculating the public against harmful health myths when standard techniques fail or backfire.
A teaching aid on addressing hesitancy to Covid-19 vaccination. WHO has identified vaccine hesitancy as a major threat to global health. Learn more about how to work with patients, the public and communities to improve confidence in Covid-19 vaccines.
Insights on Americans' perspectives on the COVID-19 vaccines, with effective language to build confidence in vaccination. Based on a poll conducted Dec. 21-22, 2020, by Frank Luntz and the de Beaumont Foundation in partnership with the American Public Health Association, the National Collaborative for Health Equity, and Resolve to Save Lives, an Initiative of Vital Strategies.
An invited presentation to the AFSA (Asian Fire Service Association) Summer conference on the need to find leadership models which work better for diverse communities and enable people to bring assets an understandings from their cultures to organisational leadership
A presentation to the SABRE Cymru conference (Social and Behavioural Science Rapid Response Network) on lessons for social and behavioural sciences in public health beyond Covid-19. https://sabrecymru.uk/
My presentation to the 175th anniversary conference of the Association of Directors of Public Health on lessons from the past and pointers for the future
A presentation to the National Immunisation Conference on lessons learned for the future of public health response to Monkeypox and other novel infections
This is part 2 of a two part session deliver for a Common Awards (Theology, Ministry and Mission, University of Durham) course on health and the Church. The first part focuses on a theological perspective and the second part focuses on public health perspectives
This is part 1 of a two part session deliver for a Common Awards (Theology, Ministry and Mission, University of Durham) course on health and the Church. The first part focuses on a theological perspective and the second part focuses on public health perspectives
This presentation was given to a webinar on addressing poverty and also contains some suggested waymarkers for response. It is based on local experience and the lessons in the LGA/ADPH Annual Public Health Report 2023
An invited keynote to the St Vincent de Paul Society Conference 2022 on emerging from the Pandemic and tasks for the Church and associated organisations
This was an invited keynote to the Social and Behavioural Sciences Rapid Response Network for Infectious Diseases (SABRE Cymru) symposium on Covid-19 and beyond.
Pastoral care is "that aspect of the ministry of the Church which is concerned with the well-being of
the individual and of the community in general." 2 It is clear that the impact of multiple traumas from
the COVID-19 pandemic creates a major challenge for pastoral care. The purpose of this publication
is to enable faith leaders to get some rapid and concise orientation on the issues of population and
community trauma, resilience, self-care and coping during and beyond the pandemic, so they can
consider strategies both for their congregations and the wider community.
This briefing seeks to provide some frameworks for response to the needs of:
1. Populations and local communities, because there will be multiple and differential impacts
on various sub-populations both by life course stage and by identity, as well as
socioeconomic status. Impacts are multiple, from losing loved, to losing jobs, to having
essential treatment delayed. All of these can be traumatic.
2. Faith communities, because as the pandemic goes on, and we are now beyond 18 months of
response, the risks of compassion fatigue, burnout and traumatic stress to congregations
increase. Psychological injury to those who are involved in 'frontline' ministry, both as
ministers or as medical and care workers, may be worse than in other parts of the
population because the combination of enduring stress and their own motivation to keep
serving their populations may result in their feeling unwilling or unable to seek help.
This briefing is set within the context of public mental health, which means it intentionally seeks to
consider what can be done at population level (e.g. whole church or workplace), and group level, not
just individual level. The right kind of action aimed at populations is just as important as action
aimed at individuals and should be seen as
complementary. This is especially so where there
are resources and capabilities which churches can
bring to bear for their whole membership, and
which can help them respond to trauma and
become resilient. In this sense, a populationhealth approach sits well with the idea of the Church as a community where healing can occur
A briefing for Public Health teams on a public mental health approach resilience, trauma and coping beyond the pandemic, and addressing the needs of communities and workplaces
A publication for government on pandemic flu and faith communities. Prepared as a sister document to Key Communities, Key Resources, a report for government on faith communities and pandemic preparedness
More from Professor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol (20)
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Vaccine hesitancy seminar primary care february 2021 v2
1. Public Health Covid Briefings
Jim McManus
Director of Public Health, Hertfordshire
Chair, Behavioural Science and Public Health
Network
Jim.mcmanus@hertfordshire.gov.uk
Strategies to reduce vaccine hesitancy
Webinar for Primary Care in Herts
11th February 2021
2. Public Health Covid Briefings
Jim McManus is Director of Public Health for Hertfordshire, Vice-
President of the Association of Directors of Public Health and Chair of the
Behavioural Science and Public Health Network
Jim is a member of the national Vaccine Deployment Steering Group and
of the National Vaccine Equalities Board representing ADPH
Jim is a registered Public Health Specialist, a Chartered Psychologist and
Chartered Scientist and a Fellow of the British Psychological Society
3. Public Health Covid Briefings
Where does a Vaccine fit into our strategy?
It looks like, for the foreseeable future, Covid isn’t going away. While it
does like every virus, mutate, it hasn’t yet evaded vaccines.
So we need to articulate a future with covid, for now
We also know that while the Vaccine does reduce risk of series illness and
death we don’t YET know that it stops transmission, like other vaccines.
So a vaccine is a part of our strategy.
4. Public Health Covid Briefings
Where does a Vaccine fit into our strategy? 2
The key things we have to continue to do for some time are:
1. Reduce the circulation of the virus as much as possible through testing,
contact tracing and successful isolation of infected people and close
contacts. This will also help reduce the number of new variants
2. Keep on with the prevention measures for a world where the virus will
circulate for some time (distance, coverings, hygiene, safe working
practices)
3. Roll out the vaccine to as many people as possible
6. Public Health Covid Briefings
Vaccine Hesitancy Defined
The SAGE Working Group on Vaccine Hesitancy:
"Vaccine hesitancy refers to delay in acceptance or refusal of
vaccination despite availability of vaccination services. Vaccine
hesitancy is complex and context specific, varying across time, place
and vaccines. It is influenced by factors such as complacency,
convenience and confidence."
Vaccine, 2015
Accept all Refuse all
Accept some, delay some,
refuse some
Accept but
unsure
Refuse but
unsure
7. Public Health Covid Briefings
What is vaccine hesitancy?
Vaccine hesitancy is NOT the same as being anti vaccine
It’s often a catch all term for people having questions, or concerns, about a vaccine. These range
from safety to religious or ethical concerns and also people who have been misinformed. It is one of
the biggest challenges in getting people to take up vaccines.
Most people who are hesitant are looking for accurate, trustworthy information that can help them
make an informed judgement
There is a significant amount of mis-information out there, and most vaccine myths have been
repeated for years
There are organisational aspects to it as well as individual
8. Public Health Covid Briefings
8
Willingness to accept a vaccine falls on a continuum
Source: US CDC
9. Public Health Covid Briefings
Vaccine Hesitancy
Review of reasons / types of objections
‒ Safety
‒ Too many vaccines, pain with injections, severe adverse reactions
‒ Necessity
‒ Disease is "natural", VPD are gone/rare/not that severe
‒ Distrust
‒ Vaccines aren't well tested, research inadequate
‒ Societal "norm"
‒ Other children unvaccinated
‒ Religious / personal choice
‒ Right to choose, parent knows what is best, disallowed by religion
10. Public Health Covid Briefings
Vaccine Hesitancy Tips
Acknowledge concerns
Remain non-judgmental
Be knowledgeable
Provide science / evidence-based information
Discuss risk / benefit
Remind / educate:
‒ Vaccines are extensively studied prior to licensure
‒ Vaccine safety monitoring does not end at licensure
11. Public Health Covid Briefings
11
From Hesitancy to Confidence
Vaccine confidence is the trust that patients,
parents, or providers have in:
‒ Recommended vaccines
‒ Providers who administer vaccines
‒ Processes and policies that lead to vaccine
development, licensure, manufacturing,
and recommendations for use
Source: US CDC
12. Public Health Covid Briefings
Getting to Confidence
We want to go from hesitancy to confidence
‒ Structural Factors
‒ Barriers to Access
‒ How you behave as clinicians
‒ Know the vaccine, Know the facts, Engage
‒ Quality and Trustworthiness of Information
‒ Quality of Information
13. Public Health Covid Briefings
A National Strategy to Reinforce Confidence in COVID-19 Vaccines
21
14. Public Health Covid Briefings
14
A component of the National Strategy to Reinforce Confidence in COVID-19 Vaccines
Tactics Engage local and national professional associations, health systems, and healthcare
personnel often and early to ensure a clear understanding of the vaccine development
and approval process, new vaccine technologies, and the benefits of vaccination.
Ensure healthcare systems and medical practices are equipped to create a culture that
builds confidence in COVID-19 vaccination.
Strengthen the capacity of healthcare professionals to have empathetic vaccine
conversations, address myths and common questions, provide tailored vaccine
information to patients, and use motivational interviewing techniques when needed.
US National Strategy
Source: US CDC
15. Public Health Covid Briefings
15
Top 6 strategies for building COVID-19 vaccine confidence
among healthcare personnel
1. Encourage senior leaders to be vaccine champions.
2. Host discussions where personnel at different levels can provide input
and ask questions.
3. Share key messages with staff through emails, breakroom posters, and
other channels.
4. Provide information and resources to healthcare teams about COVID-19
vaccines, how they are developed and monitored for safety, and how
teams can talk to others about the vaccines.
5. Talk to non-medical staff about the importance of getting vaccinated.
6. Make the decision to get vaccinated visible and celebrate it!
Source: US CDC
16. Public Health Covid Briefings
How do I address Hesitancy? Top Tips
1. Act as a role model – show that you use information only from accurate sources like NHS, science, medical
or public health and if you are having the vaccine, say so apologetically and why. Don’t get into allowing
people to question your reasons for having the vaccine, they are valid
2. Listen and show you take their questions seriously. That doesn’t mean you have to agree with them. Be
open and above all non confrontational.
3. Provide accurate, well trusted sources of information (the purpose of this toolkit)
4. Never repeat or share misinformation, only provide accurate information
5. If you don’t know the answer to a question, say so, and try to find out
6. Peer influence – A well informed peer from the same job role or community can be as powerful if not more
powerful than an expert. Personal stories people can identify with are hugely important.
7. Q and A sessions live or virtual with people who really know their facts on local media, radio or social
media
8. Promote sharing of accurate information
9. Push Techniques
17. Public Health Covid Briefings
A framework for driving uptake
Organisational Individual
Cohort • Accurate registers from which to call
people
• Understanding issues your cohort
may have
• People like ME getting vaccine
Call • Letter? Phone? Language? Advance
information?
• Language? Style? Confidence
During • Information on hand in right language • Listen and Answer
• Push not Pull “It’s time for”
Reminder • Systems for reminders across text
AND call AND letter
• The Personal touch
• Push techniques
Recall • As per call • Deal with any adverse reactions
they’ve had
EAST – Easy, Attractive, Social, Timely
18. Public Health Covid Briefings
Anti-vaxxers and vaccine skeptics
These are two very different phenomena. Vaccine skeptics are sceptical of
science for a variety of reasons. They may come round. Anti-vaxxers or
vaccine denialists are ideologically opposed to vaccines and will quote their
understanding of science
Unless you really know your science, the best way to respond is not to
engage, don’t acknowledge conspiracy theories and stick to the facts and
promoting vaccine information. You will rarely win here and there is more
to be gained from putting out accurate information.
https://theconversation.com/4-ways-to-talk-with-vaccine-skeptics-125142
19. Public Health Covid Briefings
Thank You!
We have a toolkit of messages and images we can use
21. Public Health Covid Briefings
Where do I learn more?
Some good reads
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30218-1/fulltext
Catalogue of hesitancy reduction requirements
https://www.ecdc.europa.eu/sites/default/files/documents/Catalogue-interventions-vaccine-
hesitancy.pdf
https://www.ecdc.europa.eu/en/publications-data/catalogue-interventions-addressing-vaccine-
hesitancy
https://www.mayoclinicproceedings.org/article/S0025-6196(20)31487-7/pdf
https://www.who.int/immunization/sage/meetings/2014/october/3_SAGE_WG_Strategies_addressing
_vaccine_hesitancy_2014.pdf
22. Public Health Covid Briefings
Where do I learn more?
Some materials on vaccine hesitancy here
Short read https://www.local.gov.uk/our-support/guidance-and-resources/comms-hub-
communications-support/covid-19-communications/covid-8
Longer reads
‒ https://www.hertfordshire.gov.uk/services/health-in-herts/professionals/covid-19-behavioural-
science-resources.aspx
‒ https://www.ecdc.europa.eu/en/immunisation-vaccines/vaccine-hesitancy
A podcast here https://www.bsphn.org.uk/719/Coronavirus-Mini-Series-8---Behavioural-Science-to-
Increase-Vaccine-Uptake-Jim-McManus-Wayne-Bateman-Paul-Chadwick
A useful video resource here https://www.ama-assn.org/delivering-care/public-health/covid-19-
vaccine-hesitancy-10-tips-talking-patients
https://www.hcpa.info/guideline/covid-19-vaccinations/
23. Public Health Covid Briefings
Appendix 2: Some Resources to share with
communities
24. Public Health Covid Briefings
Resources for Sharing
A video on what vaccines are (5 mins)
https://www.youtube.com/watch?v=rb7TVW77ZCs
A video from Nature journal on how they work
https://www.youtube.com/watch?v=4SKmAlQtAj8
Celebrating Vaccines – a public web resource from the British Society for
Immunology https://www.immunology.org/celebrate-vaccines
Throughout this toolkit you will see graphics designed for public use by the
British Society for Immunology. Check out their website for regular
updates
25. Public Health Covid Briefings
Faith and Covid
The majority of faith leaders from most faiths support people getting the
vaccine. Muslim, Catholic and many other official leaders have been
particularly prominent here.
FaithAction, a multi-faith agency, has a series of blogs and information
pages on faith and the vaccine which you can find here
‒ https://www.faithaction.net/blog/2021/01/28/covid-19-vaccine-early-
data-hesitancy-and-faith/
26. Public Health Covid Briefings
British Sign Language Resources
SignHealth is a registered Charity and have produced a range of videos
in British Sign Language on Covid and the vaccine
https://signhealth.org.uk/campaign/covid-19-vaccine-information/
27. Public Health Covid Briefings
NHS Videos and Leaflets
Videos in a range of Languages can be found here
https://vimeo.com/user132203718
Government leaflets for older adults in multiple languages can be
found here
30. Public Health Covid Briefings
References
Ames HMR, Glenton C, Lewin S. Parents' and caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of
qualitative evidence. Cochrane Database of Systematic Reviews, 2017, Issue 2. Art. No. CD011787. doi: 10.1002/14651858.CD011787.pub.2
Bernstein HH, Bocchini JA, Committee on Infectious Diseases. Practical approaches to optimize adolescent immunization. Pediatrics, 2017; 139(3): e1-
13. doi: 10.1542/peds.2016-4187
Centers for Disease Control at cdc.gov
de St. Maurice A, Edwards KM, Hackell J. Addressing vaccine hesitancy in clinical practice. Pediatr Ann, 2018; 47(9): e366-e370. doi: 10.3928/19382359-
20180809-01
Delamater PL, Pingali SC, Buttenheim AM, et al. Elimination of nonmedication immunization exemptions in California and school-entry vaccine
status. Pediatrics, 2019; 145(6): e20183301. doi: 10.1542/peds.2018-3301
Edwards KM, Hackell JM, Committee on Infectious Diseases. Countering vaccine hesitancy. Pediatrics, 2016; 138(3): e20162146. doi:
10.1542/peds/2016-2146
MacDonald NE, the SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine, 2015; 33: 4161-4164.
doi: 10.1016/j.vaccine.2015.04.036
Mbaeyi, S.A. Serogroup B meningococcal vaccines booster doses: Work Group interpretation, considerations
for policy options, and next steps. (Available at: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2019-02/Meningococcal-5-Mbaeyi-
508.pdf. Accessed August 15, 2019)Advisory Committee on Immunization Practices Meeting; February 28, Atlanta, GA; 2019
Nowak GJ, Cacciatore MA. Parents' confidence in recommended childhood vaccinations: extending the assessment, expanding the context. Human
Vaccines & Immunotherapeutics, 13(3): 687-700. doi: 10.10802/21645515.2016.1236881
Omar SB, Allen K, Chang DH, et al. Exemptions from mandatory immunization after legally mandated parental counseling. Pediatrics, 2018; 141(1):
e20172364. doi: 10.1542/peds.2017-2364
Editor's Notes
Definition intended to encompass the full continuum of hesitancy that falls between complete acceptance of all vaccines/no doubts and complete refusal of all vaccines – the continuum will start on the end of "accept but unsure" with "accept some, delay, refuse some" in the middle and end at "refuse but unsure"
In order to curb the pandemic, it is critical to increase demand for a COVID-19 vaccine. This slide shows how the willingness to accept a vaccine falls on a continuum.
The vaccine demand continuum illustrates behaviors, whereas confidence is both a feeling and can be acted on. Most people may fall in the middle of this spectrum with a wait-and-see approach.
We want to move people toward the right. The closer you get to active demand on the right side of the continuum, the increasing confidence the person likely feels in the vaccine, the vaccinator, and the health system, because they actively chose vaccination. This requires effort.
People vote with their feet. If there is sufficient confidence and trust and ability, then people will seek out vaccines, overcoming barriers to do so. People with less confidence or motivation or ability may have trouble overcoming barriers, such as transportation or getting time off work.
It’s also important to note that where a person falls on the continuum may depend on whether the person is considering this relative to themselves or others that they care about such as minor child, adult child with disabilities, an older adult parent, etc.
So how can we address vaccine hesitancy? By building vaccine confidence, which is a multi-faceted concept, based largely on trust.
Vaccine confidence is the trust that patients, parents, or providers have in:
recommended vaccines;
providers who administer vaccines; and
processes and policies that lead to vaccine development, licensure, manufacturing, and recommendations for use.
A person must have trust in all three of these items to feel fully confident in their decision to get vaccinated. The foundation of trust is critical, and this is something that must be built over time. This is a critical concept to think about when working with patient populations who may have a history of mistrust in the medical establishment or the government.
As providers, you obviously have an impact on the second sub-bullet – helping patients to trust you in your role as vaccine administrators.
It’s important to note, though, that you can also help build trust in vaccines as well as the processes and policies by helping your patients to understand new vaccine technologies, what to expect in terms of vaccine side effects, and how these vaccines are being continuously monitored for safety. Being honest about what you don’t know is also important for building trust.
This slide shows CDC’s Vaccinate with Confidence strategy, which aims to build confidence in COVID vaccine, the providers who vaccinate, and the vaccination system. It’s not a communication campaign, but rather a framework for thinking about interventions to increase vaccine confidence.
There are three components to the framework. The first aims to build trust by sharing clear, complete, and accurate messages about COVID-19 vaccine in collaboration with federal, state, and local agencies and partners.
The second aims to empower healthcare personnel by helping them to feel confident in their own decision to get vaccinated and to recommend vaccination to their patients. This is the element that is most important for our discussion today.
The third focuses on how to engage communities in a sustainable, equitable, and inclusive way in order to increase collaboration. This is closely related to the first element about building trust.
These are some of the tactics that CDC will be using to empower healthcare personnel.
Engaging national professional associations, health systems, and healthcare personnel often and early to ensure a clear understanding of the vaccine development and approval process, new vaccine technologies, and the benefits of vaccination.
Ensuring healthcare systems and medical practices are equipped to create a culture that builds confidence in COVID-19 vaccination.
Strengthening the capacity of healthcare professionals to have empathetic vaccine conversations, address myths and common questions, provide tailored vaccine information to patients, and use motivational interviewing techniques when needed.
As an immunization coordinator, you have an important role to play in all three of these tactics. We will talk more about this in the coming slides.
The idea of building COVID-19 vaccine confidence may seem daunting, but there are concrete steps you can take, as outlined in this slide.
Encourage senior leaders to be vaccine champions.
Host discussions where personnel at different levels can provide input and ask questions.
Share key messages with staff through emails, breakroom posters, and other channels
Provide information and resources to healthcare teams about COVID-19 vaccines, how they are developed and monitored for safety, and how teams can talk to others about the vaccines.
Talk to non-medical staff about the importance of getting vaccinated.
Make the decision to get vaccinated visible and celebrate it!
We will go through each of these steps in depth.